173
Views
0
CrossRef citations to date
0
Altmetric
Articles

Computational discovery of sulfonamide derivatives as potential inhibitors of the cruzain enzyme from T. cruzi by molecular docking, molecular dynamics and MM/GBSA approaches

, ORCID Icon & ORCID Icon
Pages 1678-1687 | Received 04 May 2022, Accepted 15 Aug 2022, Published online: 13 Sep 2022
 

ABSTRACT

Chagas disease is caused by Trypanosoma cruzi (T. cruzi) protozoan and is considered by WHO as a neglected tropical disease, affecting almost 21 countries in the Americas. Until now, only two drugs are clinically recommended for its treatment, although these have limited efficacy and cause serious adverse reactions in the patients. Particularly, the Cruzain (Cz), a cysteine protease enzyme, has been established as a therapeutic target of T. cruzi. Here, the Cz binding mode of sulfonamide derivatives was investigated using fragment-based growing, molecular docking, molecular dynamics (MD) simulations and binding free energy approaches. Here, two new potent Cz inhibitors (named CP1 and CP4) were proposed from the previously evaluated dichlorothiophene-2-sulfonamide compound (named CP6). MD simulations show that CP1 and CP4 compounds were more stable than CP6. Besides, MM/GBSA approach suggests that new proposed compounds CP1 and CP4 (–26.10 and –23.81 kcal/mol, respectively) bind to Cz active site with lower binding free energy values than CP6 (–21.79 kcal/mol). These results suggested these two compounds could be candidate inhibitors against the Cz enzyme. Hence findings in our study can provide valuable information on the discovery of potent trypanocidal agents.

Acknowledgments

This study was granted access to the computational resources of the South African Centre for High-Performance Computing (https://www.chpc.ac.za/), Hippo at the University of KwaZulu-Natal (https://astro.ukzn.ac.za/~hippo/) and the Centro de Computação de Alto Desempenho (https://www.ccad.ufpa.br/) of Universidade Federal do Pará. The authors thank to CNPq and PROPESP/UFPA for the financial support.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by CNPQ.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.